BMY vs IEX · P/E 17, rev $24.46B vs P/E 29, rev $1.81B
Bristol-Myers Squibb Company (BMY) versus IDEX Corporation (IEX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
IDEX Corporation (IEX) is a specialty industrial machinery company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported IEX revenue for 2026-06-30 was $1.81B. Net income was $263.4M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
Not investment advice. Open the BMY and IEX stock pages for the full models.
Not investment advice.